149 related articles for article (PubMed ID: 10643539)
1. The course of long-term toxicity in patients treated with cisplatin-based chemotherapy for non-seminomatous germ-cell cancer.
Petersen PM; Hansen SW
Ann Oncol; 1999 Dec; 10(12):1475-83. PubMed ID: 10643539
[TBL] [Abstract][Full Text] [Related]
2. Reproductive toxicity with and without LHRHA administration during adjuvant chemotherapy in patients with germ cell tumors.
Kreuser ED; Hetzel WD; Hautmann R; Pfeiffer EF
Horm Metab Res; 1990 Sep; 22(9):494-8. PubMed ID: 1701752
[TBL] [Abstract][Full Text] [Related]
3. Long-term fertility and Leydig cell function in patients treated for germ cell cancer with cisplatin, vinblastine, and bleomycin versus surveillance.
Hansen SW; Berthelsen JG; von der Maase H
J Clin Oncol; 1990 Oct; 8(10):1695-8. PubMed ID: 1698935
[TBL] [Abstract][Full Text] [Related]
4. Gonadal function of patients treated with cisplatin based chemotherapy for germ cell cancer.
Brennemann W; Stoffel-Wagner B; Helmers A; Mezger J; Jäger N; Klingmüller D
J Urol; 1997 Sep; 158(3 Pt 1):844-50. PubMed ID: 9258096
[TBL] [Abstract][Full Text] [Related]
5. Testicular function in patients with testicular cancer treated with orchiectomy alone or orchiectomy plus cisplatin-based chemotherapy.
Hansen PV; Trykker H; Helkjoer PE; Andersen J
J Natl Cancer Inst; 1989 Aug; 81(16):1246-50. PubMed ID: 2474077
[TBL] [Abstract][Full Text] [Related]
6. Long-term effects on renal function and blood pressure of treatment with cisplatin, vinblastine, and bleomycin in patients with germ cell cancer.
Hansen SW; Groth S; Daugaard G; Rossing N; Rørth M
J Clin Oncol; 1988 Nov; 6(11):1728-31. PubMed ID: 2460594
[TBL] [Abstract][Full Text] [Related]
7. Testicular function in poor-risk nonseminomatous germ cell tumors treated with methotrexate, paclitaxel, ifosfamide, and cisplatin combination chemotherapy.
Pectasides D; Pectasides E; Papaxoinis G; Skondra M; Gerostathou M; Karageorgopoulou S; Kamposioras C; Tountas N; Koumarianou A; Psyrri A; Macheras A; Economopoulos T
J Androl; 2009; 30(3):280-6. PubMed ID: 19136393
[TBL] [Abstract][Full Text] [Related]
8. Sequential trials of cisplatin, vinblastine, and bleomycin and etoposide and cisplatin in disseminated nonseminomatous germ cell tumors of the testis with a good prognosis at a single institution.
Germá JR; Sagarra AF; Izquierdo MA; Seguí MA
Cancer; 1993 Feb; 71(3):796-803. PubMed ID: 7679314
[TBL] [Abstract][Full Text] [Related]
9. Fertility after chemotherapy for testicular cancer.
Drasga RE; Einhorn LH; Williams SD; Patel DN; Stevens EE
J Clin Oncol; 1983 Mar; 1(3):179-83. PubMed ID: 6199473
[TBL] [Abstract][Full Text] [Related]
10. Experience with PVB in non seminomatous germ-cell cancer of the testis.
Jacquillat C; Auclerc G; Auclerc MF; Verges J; Weil M
Prog Clin Biol Res; 1985; 203():451-6. PubMed ID: 2421336
[No Abstract] [Full Text] [Related]
11. Treatment Results of Extracranial Malignant Germ Cell Tumor with Regimens of Cisplatin, Vinblastine, Bleomycin or Carboplatin, Etoposide, and Bleomycin with Special Emphasis on the Sites of Vagina and Testis.
Hou JY; Liu HC; Yeh TC; Sheu JC; Chen KH; Chang CY; Liang DC
Pediatr Neonatol; 2015 Oct; 56(5):301-6. PubMed ID: 25769700
[TBL] [Abstract][Full Text] [Related]
12. Late-effects after treatment for germ-cell cancer with cisplatin, vinblastine, and bleomycin.
Hansen SW
Dan Med Bull; 1992 Oct; 39(5):391-9. PubMed ID: 1385050
[TBL] [Abstract][Full Text] [Related]
13. Chronic gonadal toxicity in patients with testicular cancer after chemotherapy.
Kreuser ED; Harsch U; Hetzel WD; Schreml W
Eur J Cancer Clin Oncol; 1986 Mar; 22(3):289-94. PubMed ID: 2423340
[TBL] [Abstract][Full Text] [Related]
14. A randomized trial of cisplatin, vinblastine, and bleomycin versus vinblastine, cisplatin, and etoposide in the treatment of advanced germ cell tumors of the testis: a Southwest Oncology Group study.
Wozniak AJ; Samson MK; Shah NT; Crawford ED; Ford CD; Altman SJ; Stephens RL; Natale RB; Bouroncle BA; Blumenstein BA
J Clin Oncol; 1991 Jan; 9(1):70-6. PubMed ID: 1702148
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of carboplatin, etoposide, and bleomycin combination chemotherapy in good-prognosis metastatic testicular nonseminomatous germ cell tumors.
Horwich A; Dearnaley DP; Nicholls J; Jay G; Mason M; Harland S; Peckham MJ; Hendry WF
J Clin Oncol; 1991 Jan; 9(1):62-9. PubMed ID: 1702147
[TBL] [Abstract][Full Text] [Related]
16. Early resection of residual tumor during cisplatin, vinblastine, bleomycin combination chemotherapy in stage III and bulky stage II nonseminomatous testicular cancer.
Pizzocaro G; Salvioni R; Pasi M; Zanoni F; Milani A; Pilotti S; Monfardini S
Cancer; 1985 Jul; 56(2):249-55. PubMed ID: 2408728
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of long-term toxicity after chemotherapy for testicular cancer.
Bokemeyer C; Berger CC; Kuczyk MA; Schmoll HJ
J Clin Oncol; 1996 Nov; 14(11):2923-32. PubMed ID: 8918489
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy of disseminated germ cell tumors.
Einhorn LH
Cancer; 1987 Aug; 60(3 Suppl):570-3. PubMed ID: 2439185
[TBL] [Abstract][Full Text] [Related]
19. Modified cisplatin, etoposide (or vinblastine) and ifosfamide salvage therapy for male germ-cell tumors. Long-term results.
Pizzocaro G; Salvioni R; Piva L; Faustini M; Nicolai N; Gianni L
Ann Oncol; 1992 Mar; 3(3):211-6. PubMed ID: 1316779
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of long-term toxicity in patients after cisplatin-based chemotherapy for non-seminomatous testicular cancer.
Strumberg D; Brügge S; Korn MW; Koeppen S; Ranft J; Scheiber G; Reiners C; Möckel C; Seeber S; Scheulen ME
Ann Oncol; 2002 Feb; 13(2):229-36. PubMed ID: 11885999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
